gout and semaglutide GLP-1 Drugs Could Raise the Risk of Weaker Bones Semaglutide in Diabetic Kidney Disease:

PMID: 23524641

Olympia, Cutler tested positive for banned diuretics, [8] but sued and had his second-place finish reinstated

Chest CT score in COVID-19 patients: correlation with disease severity and short-term prognosis

Studies in GLP-1 receptor knockout mice have attributed lack of disturbances in glucose homeostasis to compensatory enhancement in the secretion and insulinotropic action of GIP [24]

It is investigated in preclinical and exploratory clinical research as a selective growth hormone secretagogue with reduced off-target activity at receptors such as ACTH and cortisol pathways, compared with earlier GHRPs